QQ客服 官方微博 反馈留言

浏览/检索结果: 共6条，第1-6条 帮助 限定条件 内容类型：会议论文     已选(0)清除 条数/页：5101520253035404550556065707580859095100   排序方式：请选择作者升序作者降序题名升序题名降序发表日期升序发表日期降序提交时间升序提交时间降序 FOLFIRI Regimen with or without Bevacizumab as Second-Line Therapy Showed Activity in Patients with Metastatic Gastroenteropancreatic Neuroendocrine Carcinoma 会议论文 作者:  Chen, Z.;  Zhao, X.;  Wang, C.;  Zhang, W.;  Zhu, X. 收藏  |  浏览/下载：2/0  |  提交时间：2019/12/05 nec  folfiri  bevacizumab   Preliminary analysis of FOLFIRI regimen with or without bevacizumab as second-line systemic therapy in patients with metastatic gastroenteropancreatic neuroendocrine carcinoma. 会议论文 作者:  Zhao, Xiaoying;  Wang, Chen Chen;  Zhang, Wen;  Zhu, Xiaodong;  Guo, Weijian 收藏  |  浏览/下载：6/0  |  提交时间：2019/12/05 Axitinib versus sorafenib as second-line therapy in Asian patients with metastatic renal cell carcinoma (mRCC): Results from a registrational study. 会议论文 作者:  Qin, Shukui;  Bi, Feng;  Cheng, Ying;  Guo, Jun;  Ren, Xiu Bao 收藏  |  浏览/下载：2/0  |  提交时间：2019/12/19 Axitinib versus sorafenib as second-line therapy in Asian patients with metastatic renal cell carcinoma (mRCC): Results from a registrational study. 会议论文 JOURNAL OF CLINICAL ONCOLOGY, 2012-05-20 作者:  Qin, Shukui;  Bi, Feng;  Cheng, Ying;  Guo, Jun;  Ren, Xiu Bao 收藏  |  浏览/下载：3/0  |  提交时间：2020/01/13 Capecitabine (X) plus vinorelbine (N) as second-line therapy in Chinese patients (pts) with metastatic breast cancer (MBC). 会议论文 41st Annual Meeting of the American-Society-of-Clinical-Oncology, MAY 13-17, 2005 作者:  Xu, B;  Tian, L;  Wu, Q;  Zhou, M;  Wang, H 收藏  |  浏览/下载：1/0  |  提交时间：2019/12/31 Capecitabine (X) plus vinorelbine (N) as second-line therapy in Chinese patients (pts) with metastatic breast cancer (MBC). 会议论文 作者:  Xu, B;  Tian, L;  Wu, Q;  Zhou, M;  Wang, H 收藏  |  浏览/下载：1/0  |  提交时间：2019/12/27